Abstract Body

Persons living with HIV(PLWH) well-treated on antiretroviral therapies remain at risk for ensuing arterial inflammation. The exact mechanism for inflammatory-mediated cardiovascular disease (CVD) in HIV remains unclear. HIV lipodystrophy has been associated with advanced metabolic disease. In this regard, visceral adipose tissue (VAT) accumulation and subcutaneous adipose tissue (SAT) loss contribute to a unique and highly inflamed adipose depot. Therefore, we sought to investigate the relationship between adipose depots and specific markers of arterial inflammation to gain insight into the potential link between lipodystrophy and CVD risk.

155 PLWH and 71 individuals without HIV(PLWOH) and no known CVD were previously recruited and well-phenotyped for body composition. VAT and SAT were assessed via single slice CT abdomen imaging. Circulating markers of arterial inflammation [lipoprotein-associated phospholipase A2(LpPLA2), oxidized LDL(oxLDL), high sensitivity troponin T(hsTnT), high sensitivity C reactive protein(hsCRP)] were evaluated. Relationships were assessed by Spearman’s correlation.

PLWH(mean age 47±1yrs, duration HIV 14±1yrs, duration ART 8±0yrs, CD4+ count 552±24cells/μL, logVL 1.82±0.04copies/mL) were of similar age and sex vs. PLWOH. Despite similar BMI and VAT, PLWH(199[126,288] vs. 239[148,358]cm2,P=.04) had significantly lower SAT compared to PLWOH. Reduced SAT was inversely correlated with LpPLA2(ρ=-0.19, P=.02) and hsTNT(ρ=-0.24, P=.004) among PLWH. Furthermore, increased VAT was significantly and positively related to LpPLA2(ρ=0.25, P=.003), oxLDL(ρ=0.28, P=.0005), hsTNT(ρ=0.28, P=.0007), and hsCRP (ρ=0.32, P=<.0001) among the HIV group. Similar analyses among PLWOH revealed significant relationships between SAT and LpPLA2(ρ=-0.24, P=.05), as well as VAT and LpPLA2(ρ=0.37, P=.002), oxLDL(ρ=0.28, P=.05), and hsCRP (ρ=0.29, P=.002). In separate models simultaneously controlling for VAT, SAT, age, CD4+ count, and viral load among PLWH, reduced SAT was an independent predictor of LpPLA2(P=.006) and increased VAT was an independent predictor of LpPLA2(P=.007) and oxLDL(P=.004).

Highly inflamed adipose tissue, in the context of SAT loss and/or VAT accumulation, may be linked to arterial inflammation. Strategies to reduce lipodystrophy and restore normal adipose biology may have therapeutic benefit to dampen arterial inflammation in the HIV population among whom traditional risk factor modification does not completely mitigate CVD risk.